Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
Abstract Background Photodynamic therapy (PDT) features high biocompatibility and high spatiotemporal selectivity, showing a great potential in glioblastoma (GBM) treatment. However, its application was restricted by the poor therapeutic efficacy and side effect. Results In this study, a therapeutic...
Saved in:
Main Authors: | Juan Ge, Miaomiao Zuo, Qirong Wang, Zhen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-01802-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurocognitive function and health-related quality of life among glioblastoma patients: A prospective study
by: Mohamed A Baba, et al.
Published: (2025-01-01) -
Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials
by: Yuanyuan Chen, et al.
Published: (2025-02-01) -
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01) -
A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors
by: Joan Nieves, et al.
Published: (2025-02-01) -
Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations
by: Alireza Shadab, et al.
Published: (2025-02-01)